» Articles » PMID: 35887881

Prevalence of Cigarette Smoking Among Professionally Active Adult Population in Poland and Its Strong Relationship with Cardiovascular Co-Morbidities-POL-O-CARIA 2021 Study

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Jul 27
PMID 35887881
Authors
Affiliations
Soon will be listed here.
Abstract

Smoking is a leading cause of preventable mortality. It affects both the health and economic situation within societies. The aim of the study is to perform an epidemiological analysis of smoking among professionally active adults in Poland in the years 2016-2020 and its Strong Relationship with Cardiovascular Co-morbidities. The article retrospectively analyzed the records of 1,450,455 who underwent occupational medicine examinations between 2016 and 2020. Statistical analyses performed using IBM SPSS Statistics 25 software were performed. In general, irrespective of the year of measurement, 11.6% of women and 17.1% of men declared smoking. After sorting by year of measurement, we found that the percentage of female smokers was decreasing, while that of males remained relatively consistent. In the case of BMI, it was found that among tobacco smokers the percentage of people with normal body weight decreases with successive years of measurement, while the percentage of overweight and level I obesity increases. Moreover, we analyzed in detail the occurrence of particular comorbidities in the group of people who declared smoking. The most common diseases in this group were: arterial hypertension (39%), lipid disorders (26.7%), and hypertension and lipid disorders (16.5%). Active preventive measures are necessary to reduce the number of smokers and the negative impact of smoking on the occurrence of comorbid diseases.

Citing Articles

Impact of global smoking prevalence on mortality: a study across income groups.

De Silva R, Silva D, Piumika L, Abeysekera I, Jayathilaka R, Rajamanthri L BMC Public Health. 2024; 24(1):1786.

PMID: 38965521 PMC: 11225136. DOI: 10.1186/s12889-024-19336-6.


Forging Ahead in Cardiovascular Disease Management.

Domienik-Karlowicz J, Ciurzynski M J Clin Med. 2023; 12(17).

PMID: 37685805 PMC: 10488857. DOI: 10.3390/jcm12175739.

References
1.
Friedman R, Sengupta N, Lees M . Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban. Expert Rev Pharmacoecon Outcomes Res. 2011; 11(3):299-306. DOI: 10.1586/erp.11.15. View

2.
Chiolero A, Faeh D, Paccaud F, Cornuz J . Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008; 87(4):801-9. DOI: 10.1093/ajcn/87.4.801. View

3.
. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1345-1422. PMC: 5614451. DOI: 10.1016/S0140-6736(17)32366-8. View

4.
. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

5.
Hanewinkel R, Isensee B, Sargent J, Morgenstern M . Cigarette advertising and teen smoking initiation. Pediatrics. 2011; 127(2):e271-8. DOI: 10.1542/peds.2010-2934. View